Skip to main content
Erschienen in: Medical Microbiology and Immunology 2/2008

01.06.2008 | Original Investigation

Hematopoietic stem cell transplantation with latently infected donors does not transmit virus to immunocompromised recipients in the murine model of cytomegalovirus infection

verfasst von: Christof K. Seckert, Angélique Renzaho, Matthias J. Reddehase, Natascha K. A. Grzimek

Erschienen in: Medical Microbiology and Immunology | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

Hematopoietic stem cell transplantation (HSCT) bears a risk of reactivating latent cytomegalovirus (CMV) in either the transplanted hematopoietic donor cells or in parenchymal and stromal tissue cells of the immunocompromised recipient, or in both. While reactivated human CMV in recipients of organ transplantations is frequently the virus variant of the donor, this is not usually the case in HSCT recipients. Here we have used experimental sex-mismatched HSCT in the BALB/c mouse model to test if latent murine CMV from CMV-immune donors is transmitted with bone marrow cells to naive immunocompromised recipients.
Literatur
1.
Zurück zum Zitat Appelbaum FR (2003) The current status of hematopoietic cell transplantation. Annu Rev Med 54:491–512PubMedCrossRef Appelbaum FR (2003) The current status of hematopoietic cell transplantation. Annu Rev Med 54:491–512PubMedCrossRef
2.
Zurück zum Zitat Kolb HJ, Schmid C, Barrett AJ, Schendel DJ (2004) Graft-versus-leukemia reactions in allogeneic chimeras. Blood 103:767–776PubMedCrossRef Kolb HJ, Schmid C, Barrett AJ, Schendel DJ (2004) Graft-versus-leukemia reactions in allogeneic chimeras. Blood 103:767–776PubMedCrossRef
3.
Zurück zum Zitat Hebart H, Einsele H (2004) Clinical aspects of CMV infection after stem cell transplantation. Hum Immunol 65:432–436PubMedCrossRef Hebart H, Einsele H (2004) Clinical aspects of CMV infection after stem cell transplantation. Hum Immunol 65:432–436PubMedCrossRef
4.
Zurück zum Zitat Riddell SR (1995) Pathogenesis of cytomegalovirus pneumonia in immunocompromised hosts. Semin Respir Infect 10:199–208PubMed Riddell SR (1995) Pathogenesis of cytomegalovirus pneumonia in immunocompromised hosts. Semin Respir Infect 10:199–208PubMed
5.
Zurück zum Zitat Wills MR, Carmichael AJ, Patrick Sissons JG (2006) Adaptive cellular immunity to human cytomegalovirus. In: Reddehase MJ (ed) Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, Norfolk, pp 341–365 Wills MR, Carmichael AJ, Patrick Sissons JG (2006) Adaptive cellular immunity to human cytomegalovirus. In: Reddehase MJ (ed) Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, Norfolk, pp 341–365
6.
Zurück zum Zitat Maciejewski JP, Bruening EE, Donahue RE, Mocarski ES, Young NS, St Jeor SC (1992) Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 80:170–178PubMedCrossRef Maciejewski JP, Bruening EE, Donahue RE, Mocarski ES, Young NS, St Jeor SC (1992) Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 80:170–178PubMedCrossRef
7.
Zurück zum Zitat Mendelson M, Monard S, Sissons P, Sinclair J (1996) Detection of endogenous cytomegalovirus in CD34+ bone marrow progenitors. J Gen Virol 77:3099–3102PubMedCrossRef Mendelson M, Monard S, Sissons P, Sinclair J (1996) Detection of endogenous cytomegalovirus in CD34+ bone marrow progenitors. J Gen Virol 77:3099–3102PubMedCrossRef
8.
Zurück zum Zitat Söderberg-Nauclér C, Fish KN, Nelson JA (1997) Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91:119–126PubMedCrossRef Söderberg-Nauclér C, Fish KN, Nelson JA (1997) Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91:119–126PubMedCrossRef
9.
Zurück zum Zitat Hahn G, Jores R, Mocarski ES (1998) Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci USA 95:3937–3942PubMedPubMedCentralCrossRef Hahn G, Jores R, Mocarski ES (1998) Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci USA 95:3937–3942PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Bolovan-Fritts CA, Mocarski ES, Wiedeman JA (1999) Peripheral blood CD14+ cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. Blood 93:394–398PubMedCrossRef Bolovan-Fritts CA, Mocarski ES, Wiedeman JA (1999) Peripheral blood CD14+ cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. Blood 93:394–398PubMedCrossRef
12.
Zurück zum Zitat Goodrum FD, Jordan CT, High K, Shenk T (2002) Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency. Proc Natl Acad Sci USA 99:16255–16260PubMedPubMedCentralCrossRef Goodrum FD, Jordan CT, High K, Shenk T (2002) Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency. Proc Natl Acad Sci USA 99:16255–16260PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Goodrum F, Jordan CT, Terhune SS, High K, Shenk T (2004) Differential outcomes of human cytomegalovirus infection in primitive hematopoietic cell subpopulations. Blood 104:687–695PubMedCrossRef Goodrum F, Jordan CT, Terhune SS, High K, Shenk T (2004) Differential outcomes of human cytomegalovirus infection in primitive hematopoietic cell subpopulations. Blood 104:687–695PubMedCrossRef
14.
Zurück zum Zitat Reeves MB, MacAry PA, Lehner PJ, Sissons JG, Sinclair JH (2005) Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci USA 102:4140–4145PubMedPubMedCentralCrossRef Reeves MB, MacAry PA, Lehner PJ, Sissons JG, Sinclair JH (2005) Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci USA 102:4140–4145PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Goodrum F, Reeves M, Sinclair J, High K, Shenk T (2007) Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro. Blood 110:937–945PubMedPubMedCentralCrossRef Goodrum F, Reeves M, Sinclair J, High K, Shenk T (2007) Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro. Blood 110:937–945PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Jarvis MA, Nelson JA (2002) Human cytomegalovirus persistence and latency in endothelial cells and macrophages. Curr Opin Microbiol 5:403–407PubMedCrossRef Jarvis MA, Nelson JA (2002) Human cytomegalovirus persistence and latency in endothelial cells and macrophages. Curr Opin Microbiol 5:403–407PubMedCrossRef
17.
Zurück zum Zitat Streblow DN, Nelson JA (2003) Models of HCMV latency and reactivation. Trends Microbiol 11:293–295PubMedCrossRef Streblow DN, Nelson JA (2003) Models of HCMV latency and reactivation. Trends Microbiol 11:293–295PubMedCrossRef
18.
Zurück zum Zitat Sinclair J, Sissons P (2006) Latency and reactivation of human cytomegalovirus. J Gen Virol 87:1763–1779PubMedCrossRef Sinclair J, Sissons P (2006) Latency and reactivation of human cytomegalovirus. J Gen Virol 87:1763–1779PubMedCrossRef
19.
Zurück zum Zitat Bain M, Reeves M, Sinclair J (2006) Regulation of human cytomegalovirus gene expression by chromatin remodelling. In: Reddehase MJ (ed) Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, Norfolk, pp 167–183 Bain M, Reeves M, Sinclair J (2006) Regulation of human cytomegalovirus gene expression by chromatin remodelling. In: Reddehase MJ (ed) Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, Norfolk, pp 167–183
20.
Zurück zum Zitat Reeves M, Sinclair J (2008) Aspects of human cytomegalovirus latency and reactivation. In: Shenk TE, Stinski MF (eds) Human cytomegalovirus. Current topics in microbiology and immunology, vol 325. Springer, Heidelberg, pp 297–314 Reeves M, Sinclair J (2008) Aspects of human cytomegalovirus latency and reactivation. In: Shenk TE, Stinski MF (eds) Human cytomegalovirus. Current topics in microbiology and immunology, vol 325. Springer, Heidelberg, pp 297–314
21.
Zurück zum Zitat Simmons P, Kaushansky K, Torok-Storb B (1990) Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells. Proc Natl Acad Sci USA 87:1386–1390PubMedPubMedCentralCrossRef Simmons P, Kaushansky K, Torok-Storb B (1990) Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells. Proc Natl Acad Sci USA 87:1386–1390PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Shenk T (2006) Human cytomegalovirus genomics. In: Reddehase MJ (ed) Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, Norfolk, pp 49–61 Shenk T (2006) Human cytomegalovirus genomics. In: Reddehase MJ (ed) Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, Norfolk, pp 49–61
23.
Zurück zum Zitat Emery VC (1998) Relative importance of cytomegalovirus load as a risk factor for cytomegalovirus disease in the immunocompromised host. In: Scholz M, Rabenau HF, Doerr HW, Cinatl J Jr (eds) Monographs in virology 21: CMV-related immunopathology. Karger, Basel, pp 288–301 Emery VC (1998) Relative importance of cytomegalovirus load as a risk factor for cytomegalovirus disease in the immunocompromised host. In: Scholz M, Rabenau HF, Doerr HW, Cinatl J Jr (eds) Monographs in virology 21: CMV-related immunopathology. Karger, Basel, pp 288–301
24.
Zurück zum Zitat Grundy JE, Lui SF, Super M, Berry NJ, Sweny P, Fernando ON, Moorhead J, Griffiths PD (1988) Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus. Lancet 16:132–135CrossRef Grundy JE, Lui SF, Super M, Berry NJ, Sweny P, Fernando ON, Moorhead J, Griffiths PD (1988) Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus. Lancet 16:132–135CrossRef
25.
Zurück zum Zitat Reddehase MJ, Podlech J, Grzimek NK (2002) Mouse models of cytomegalovirus: overview. J Clin Virol 25:S23–S36PubMedCrossRef Reddehase MJ, Podlech J, Grzimek NK (2002) Mouse models of cytomegalovirus: overview. J Clin Virol 25:S23–S36PubMedCrossRef
26.
Zurück zum Zitat Hummel M, Abecassis MM (2002) A model for reactivation of CMV from latency. J Clin Virol 25:S123–S136PubMedCrossRef Hummel M, Abecassis MM (2002) A model for reactivation of CMV from latency. J Clin Virol 25:S123–S136PubMedCrossRef
27.
Zurück zum Zitat Simon CO, Seckert CK, Grzimek NKA, Reddehase MJ (2006) Murine model of cytomegalovirus latency and reactivation: the silencing/desilencing and immune sensing hypothesis. In: Reddehase MJ (ed) Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, Norfolk, pp 483–500 Simon CO, Seckert CK, Grzimek NKA, Reddehase MJ (2006) Murine model of cytomegalovirus latency and reactivation: the silencing/desilencing and immune sensing hypothesis. In: Reddehase MJ (ed) Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, Norfolk, pp 483–500
28.
Zurück zum Zitat Reddehase MJ, Simon CO, Seckert CK, Lemmermann N, Grzimek NKA (2008) Murine model of cytomegalovirus latency and reactivation. In: Shenk TE, Stinski MF (eds) Human cytomegalovirus. Current topics in microbiology and immunology, vol 325. Springer, Heidelberg, pp 315–332 Reddehase MJ, Simon CO, Seckert CK, Lemmermann N, Grzimek NKA (2008) Murine model of cytomegalovirus latency and reactivation. In: Shenk TE, Stinski MF (eds) Human cytomegalovirus. Current topics in microbiology and immunology, vol 325. Springer, Heidelberg, pp 315–332
29.
Zurück zum Zitat Mayer A, Podlech J, Kurz S, Steffens HP, Maiberger S, Thalmeier K, Angele P, Dreher L, Reddehase MJ (1997) Bone marrow failure by cytomegalovirus is associated with an in vivo deficiency in the expression of essential stromal hemopoietin genes. J Virol 71:4589–4598PubMedPubMedCentralCrossRef Mayer A, Podlech J, Kurz S, Steffens HP, Maiberger S, Thalmeier K, Angele P, Dreher L, Reddehase MJ (1997) Bone marrow failure by cytomegalovirus is associated with an in vivo deficiency in the expression of essential stromal hemopoietin genes. J Virol 71:4589–4598PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Steffens HP, Podlech J, Kurz S, Angele P, Dreis D, Reddehase MJ (1998) Cytomegalovirus inhibits the engraftment of donor bone marrow cells by downregulation of hemopoietin gene expression in recipient stroma. J Virol 72:5006–5015PubMedPubMedCentralCrossRef Steffens HP, Podlech J, Kurz S, Angele P, Dreis D, Reddehase MJ (1998) Cytomegalovirus inhibits the engraftment of donor bone marrow cells by downregulation of hemopoietin gene expression in recipient stroma. J Virol 72:5006–5015PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Podlech J, Holtappels R, Grzimek NKA, Reddehase MJ (2002) Animal models: murine cytomegalovirus. In: Kaufmann SHE, Kabelitz D (eds) Methods in microbiology 32. Immunology of infection. Academic Press, San Diego, pp 493–525CrossRef Podlech J, Holtappels R, Grzimek NKA, Reddehase MJ (2002) Animal models: murine cytomegalovirus. In: Kaufmann SHE, Kabelitz D (eds) Methods in microbiology 32. Immunology of infection. Academic Press, San Diego, pp 493–525CrossRef
32.
Zurück zum Zitat Simon CO, Seckert CK, Dreis D, Reddehase MJ, Grzimek NK (2002) Role for tumor necrosis alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs. J Virol 79:326–340CrossRef Simon CO, Seckert CK, Dreis D, Reddehase MJ, Grzimek NK (2002) Role for tumor necrosis alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs. J Virol 79:326–340CrossRef
33.
Zurück zum Zitat Dobonici M, Podlech J, Steffens HP, Maiberger S, Reddehase MJ (1998) Evidence against a key role for transforming growth factor-beta1 in cytomegalovirus-induced bone marrow aplasia. J Gen Virol 79:867–876PubMedCrossRef Dobonici M, Podlech J, Steffens HP, Maiberger S, Reddehase MJ (1998) Evidence against a key role for transforming growth factor-beta1 in cytomegalovirus-induced bone marrow aplasia. J Gen Virol 79:867–876PubMedCrossRef
34.
Zurück zum Zitat Holtappels R, Podlech J, Geginat G, Steffens HP, Thomas D, Reddehase MJ (1998) Control of murine cytomegalovirus in the lungs: relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates. J Virol 72:7201–7212PubMedPubMedCentralCrossRef Holtappels R, Podlech J, Geginat G, Steffens HP, Thomas D, Reddehase MJ (1998) Control of murine cytomegalovirus in the lungs: relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates. J Virol 72:7201–7212PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Podlech J, Holtappels R, Wirtz N, Steffens HP, Reddehase MJ (1998) Reconstitution of CD8 T cells is essential for the prevention of multiple-organ cytomegalovirus histopathology after bone marrow transplantation. J Gen Virol 79:2099–2104PubMedCrossRef Podlech J, Holtappels R, Wirtz N, Steffens HP, Reddehase MJ (1998) Reconstitution of CD8 T cells is essential for the prevention of multiple-organ cytomegalovirus histopathology after bone marrow transplantation. J Gen Virol 79:2099–2104PubMedCrossRef
36.
Zurück zum Zitat Podlech J, Holtappels R, Pahl-Seibert M-F, Steffens HP, Reddehase MJ (2000) Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection. J Virol 74:7496–7507PubMedPubMedCentralCrossRef Podlech J, Holtappels R, Pahl-Seibert M-F, Steffens HP, Reddehase MJ (2000) Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection. J Virol 74:7496–7507PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Simon CO, Holtappels R, Tervo HM, Böhm V, Däubner T, Oehrlein-Karpi SA, Kühnapfel B, Renzaho A, Strand D, Podlech J, Reddehase MJ, Grzimek NK (2006) CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation. J Virol 80:10436–10456PubMedPubMedCentralCrossRef Simon CO, Holtappels R, Tervo HM, Böhm V, Däubner T, Oehrlein-Karpi SA, Kühnapfel B, Renzaho A, Strand D, Podlech J, Reddehase MJ, Grzimek NK (2006) CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation. J Virol 80:10436–10456PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Holtappels R, Munks MW, Podlech J, Reddehase MJ (2006) CD8 T-cell-based immunotherapy of cytomegalovirus disease in the mouse model of the immunocompromised bone marrow transplantation recipient. In: Reddehase MJ (ed) Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, Norfolk, pp 383–418 Holtappels R, Munks MW, Podlech J, Reddehase MJ (2006) CD8 T-cell-based immunotherapy of cytomegalovirus disease in the mouse model of the immunocompromised bone marrow transplantation recipient. In: Reddehase MJ (ed) Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, Norfolk, pp 383–418
39.
40.
Zurück zum Zitat Balthesen M, Dreher L, Lučin P, Reddehase MJ (1994) The establishment of cytomegalovirus latency in organs is not linked to local virus production during primary infection. J Gen Virol 75:2329–2336PubMedCrossRef Balthesen M, Dreher L, Lučin P, Reddehase MJ (1994) The establishment of cytomegalovirus latency in organs is not linked to local virus production during primary infection. J Gen Virol 75:2329–2336PubMedCrossRef
41.
Zurück zum Zitat Kurz S, Steffens HP, Mayer A, Harris JR, Reddehase MJ (1997) Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J Virol 71:2980–2987PubMedPubMedCentralCrossRef Kurz S, Steffens HP, Mayer A, Harris JR, Reddehase MJ (1997) Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J Virol 71:2980–2987PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Balthesen M, Šuša M, Lučin P, Reddehase MJ (1994) Cytomegalovirus DNA detected in blood leukocytes after resolution of productive infection does not originate from latently infected hematopoietic stem cells in the bone marrow. Croat Med J 35:19–25 Balthesen M, Šuša M, Lučin P, Reddehase MJ (1994) Cytomegalovirus DNA detected in blood leukocytes after resolution of productive infection does not originate from latently infected hematopoietic stem cells in the bone marrow. Croat Med J 35:19–25
43.
Zurück zum Zitat Digel M, Sinzger C (2006) Determinants of endothelial cell tropism of human cytomegalovirus. In: Reddehase MJ (ed) Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, Norfolk, pp 445–464 Digel M, Sinzger C (2006) Determinants of endothelial cell tropism of human cytomegalovirus. In: Reddehase MJ (ed) Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, Norfolk, pp 445–464
44.
Zurück zum Zitat Wagner M, Jonjić S, Koszinowski UH, Messerle M (1999) Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J Virol 73:7056–7060PubMedPubMedCentralCrossRef Wagner M, Jonjić S, Koszinowski UH, Messerle M (1999) Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J Virol 73:7056–7060PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Grzimek NK, Podlech J, Steffens HP, Holtappels R, Schmalz S, Reddehase MJ (1999) In vivo replication of recombinant murine cytomegalovirus driven by the paralogous major immediate-early promoter-enhancer of human cytomegalovirus. J Virol 73:5043–5055PubMedPubMedCentralCrossRef Grzimek NK, Podlech J, Steffens HP, Holtappels R, Schmalz S, Reddehase MJ (1999) In vivo replication of recombinant murine cytomegalovirus driven by the paralogous major immediate-early promoter-enhancer of human cytomegalovirus. J Virol 73:5043–5055PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Busch FW, Mutter W, Koszinowski UH, Reddehase MJ (1991) Rescue of myeloid lineage-committed preprogenitor cells from cytomegalovirus-infected bone marrow stroma. J Virol 65:981–984PubMedPubMedCentralCrossRef Busch FW, Mutter W, Koszinowski UH, Reddehase MJ (1991) Rescue of myeloid lineage-committed preprogenitor cells from cytomegalovirus-infected bone marrow stroma. J Virol 65:981–984PubMedPubMedCentralCrossRef
47.
Zurück zum Zitat Reddehase MJ, Balthesen M, Rapp M, Jonjić S, Pavić I, Koszinowski UH (1994) The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J Exp Med 179:185–193PubMedCrossRef Reddehase MJ, Balthesen M, Rapp M, Jonjić S, Pavić I, Koszinowski UH (1994) The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J Exp Med 179:185–193PubMedCrossRef
48.
Zurück zum Zitat Steffens HP, Kurz S, Holtappels R, Reddehase MJ (1998) Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence. J Virol 72:1797–1804PubMedPubMedCentralCrossRef Steffens HP, Kurz S, Holtappels R, Reddehase MJ (1998) Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence. J Virol 72:1797–1804PubMedPubMedCentralCrossRef
Metadaten
Titel
Hematopoietic stem cell transplantation with latently infected donors does not transmit virus to immunocompromised recipients in the murine model of cytomegalovirus infection
verfasst von
Christof K. Seckert
Angélique Renzaho
Matthias J. Reddehase
Natascha K. A. Grzimek
Publikationsdatum
01.06.2008
Verlag
Springer Berlin Heidelberg
Erschienen in
Medical Microbiology and Immunology / Ausgabe 2/2008
Print ISSN: 0300-8584
Elektronische ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-008-0094-1

Weitere Artikel der Ausgabe 2/2008

Medical Microbiology and Immunology 2/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.